SHINE Medical Technologies has completed exterior construction of its medical isotope production facility and made it weathertight for protection, the company announced today. According to a release, the facility can withstand…
SHINE Medical Technologies broke ground on its 54,000-square-foot corporate headquarters and therapeutics production facility in Janesville, Wis., the company announced recently. “The best work we do at SHINE is the…
SHINE Medical Technologies will add a “supercell,” a bank of 10 hot cells, for its medical isotope production facility in Janesville, Wis., the company announced recently. According to a release,…
SHINE Medical Technologies Therapeutics division has made its first commercial sale of lutetium-177, a therapeutic isotope in demand by clinical trial sponsors, the company announced recently. “This milestone is really exciting,…
SHINE Medical Technologies has closed an $80 million Series C financing round, the company announced recently. “This funding round will help SHINE’s continuing efforts to commercialize vital diagnostic and therapeutic…
The U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE Medical Technologies by October 2021, the company announced today….
SHINE Medical Technologies recently announced its 2019 year-end report, which included updates on its construction progress, continued investor support, its new therapeutics division and information about commercial and regulatory news….
SHINE Medical Technologies announced recently that it closed a $50 million financing round with Oaktree Capital Management. According to a release, the funds will be for the construction of SHINE’s medical…
SHINE Medical Technologies and Phoenix set a world record for a nuclear fusion reaction in a steady-state system, the strongest of its kind ever produced on Earth, SHINE announced today….
SHINE Medical Technologies added former House Speaker Paul Ryan to its board of directors, the company announced recently. “Paul is a visionary with a wealth of experience and an expansive…
